Tampa, FL (PRWEB) March 9, 2006
A revolutionary advance in cataract surgery will be introduced this month by Dr. Antonio Prado of the Prado Vision & Lasik Center at 7522 N. Himes Avenue.
AcrySof® ReSTOR® IOL is the first and only apodized diffractive intraocular lens (IOL) for cataract patients with and without presbyopia. The AcrySof® ReSTOR® IOL, from Alcon, Inc., provides patients with a full range of quality vision (near, intermediate and distance), and greatly reduces reliance on glasses.
In clinical trials, 80 percent of patients reported they no longer needed reading glasses or bifocals following bilateral cataract surgery.
Most patients who undergo cataract surgery receive monofocal lenses, which typically require them to use reading glasses or bifocals for near vision following surgery.
“With the new AcrySof® ReSTOR® IOL, patients have the potential to reduce their reliance on glasses,” said Dr. Prado. “This new lens is a breakthrough in cataract surgery, and we are proud to offer it to our patients.”
AcrySof® ReSTOR® is a foldable IOL and represents breakthrough technology. Its patented optic design allows patients to experience the highest level of freedom from glasses ever achieved in IOL clinical trials.
The AcrySof® ReSTOR® IOL uses a combination of three complementary technologies -- apodization, diffraction and refraction – which allow patients to experience a full range of high-quality vision without the need for reading glasses or bifocals. Alcon patented the application of apodization technology to an IOL, making AcrySof® ReSTOR® the first and only apodized diffractive IOL.
The AcrySof® ReSTOR® IOL received approval by the U.S. Food and Drug Administration in March 2005, and clinical trials were conducted on 566 patients in the U.S. and Europe.
Since its introduction outside the U.S. in 2003, more than 11,000 AcrySof® ReSTOR® IOLs have been implanted by more than 1,000 surgeons in Europe and elsewhere.
A cataract is a “clouding” of the eye’s natural lens, which results in blurred or defocused vision. According to a recent article published in the Archives of Ophthalmology, more than 20 million Americans have cataracts, making it the nation’s #1 cause of poor vision. According to the National Eye Institute, the number of Americans with cataracts is expected to rise to over 30 million people by the year 2020.
Nearly 3 million cataract procedures are annually performed in the U.S. Cataracts cannot be prevented and are the leading cause of treatable blindness worldwide.
About the Prado Vision & Lasik Center
Founded in Tampa, Fla. by Dr. Antonio Prado, a leading ophthalmologist and laser eye surgeon in Tampa, Prado Vision Center is comprised of the top ophthalmologists, optometrists, and eye care professionals in the Tampa Bay area. Its doctors and professional staff are dedicated to providing the community with the most comprehensive eye care services available. Prado Vision Center caters to both English-speaking and Spanish-speaking patients -- Dr. Prado and his staff are fluently bilingual.
# # #